Evaluate how well global health financing architectures such as the Global Fund hold up in an era of donor fatigue. What lessons does this hold for India's health diplomacy?

Global health financing systems such as the Global Fund pool donor pledges to fight diseases like TB in poorer countries. The WHO Global TB Report 2026 found that international donor funding for TB fell 14%, to $0.94 billion, in 2025 [1]. The system is bending under donor fatigue, but it has not broken.

Where the architecture holds up

• Core services held: As of August 2025, TB treatment was the least-affected service in the 17 countries that depended on both the Global Fund and USAID [2].
• Countries took more ownership: 86% of TB spending in 2025 came from domestic sources [1]. BRICS countries funded 96% of their own TB budgets in 2024 [2].
• Steady record: Donor funding stayed at $1.1–1.3 billion a year from 2015 to 2024 [1].

Where it falls short

• Reliance on one donor: The US gave about half of all international TB donor funding and about a third of contributions to the Global Fund [2]. The Global Fund's 2024–26 grant cycle was cut by US$1.4 billion (11%) [2].
• Not enough money: About $6.6 billion is available against the $22 billion a year needed to meet the UNHLM 2027 targets. TB research gets $1.2 billion against a $5 billion target [1].
• Unequal impact: The 86% average hides how much poorer countries outside BRICS still depend on donors. More than 80% of TB cases and deaths occur in low- and middle-income countries [1]. WHO modelling warns of up to 2 million extra deaths by 2035 if the cuts continue [2].

Verdict: The architecture can absorb short shocks, but it cannot raise funding to the level needed. Its resilience is moderate and depends on a narrow set of donors.

Lessons for India's health diplomacy

• Self-reliance gives credibility: India's TB incidence fell 21%, from 237 to 187 per lakh (2015–2024) [3]. India can offer TB Mukt Bharat as a model for the Global South.
• More donors, more pooling: India can use BRICS and G20 platforms to build funding pools that do not depend on one donor.
• Lead on research: The WHO South-East Asia Region has 35% of new TB cases [1]. India should co-fund vaccines and diagnostics through South-South partnerships and supply affordable generic medicines.
• Regional health security: India can support neighbours' TB programmes, in line with WHO's call for the region to speed up action [1].

Global health financing is moving from charity to shared responsibility. If India pairs domestic commitment with pooled, multi-donor models and joint research, it can help make health financing more resilient and move the world closer to SDG 3.3, ending the TB epidemic by 2030.